Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine

Sickle-cell disease (SCD) is an inherited hemoglobinopathy, causing lifelong complications such as painful vaso-occlusive episodes, acute chest syndrome, stroke, chronic anemia, and end-organ damage, with negative effects on quality of life and life expectancy. Within the last five years, three new...

Descripción completa

Detalles Bibliográficos
Autores principales: Migotsky, Michael, Beestrum, Molly, Badawy, Sherif M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610018/
https://www.ncbi.nlm.nih.gov/pubmed/36287444
http://dx.doi.org/10.3390/pharmacy10050123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610018/
https://www.ncbi.nlm.nih.gov/pubmed/36287444
http://dx.doi.org/10.3390/pharmacy10050123

Ejemplares similares